作为癌症免疫治疗的双重激动剂的双重OX40 Aptamer和CpG
Tingting Jiang1,2, Zailin Yang1,2, Qiuyu Su1
1College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
ACS applied materials & interfaces
|January 22, 2025
概括
这项研究将一种新型OX40激动剂阿巴 (biROX40) 与CpG结合起来,用于治疗淋巴瘤. 低剂量组合疗法增强了免疫反应,显示出显著的抗瘤疗效,并防止瘤复发.
科学领域:
- 免疫学和癌症治疗疗法
- 分子生物学和药物开发
背景情况:
- 癌症免疫疗法已经取得了显著的进步,但针对神经刺激受体的激素抗体在临床上表现不佳.
- 高剂量单剂疗法可能导致免疫细胞耗尽,限制有效性.
- 需要新的策略来克服癌症治疗中的这些局限性.
研究的目的:
- 开发和评估一种新的临床结合疗法用于淋巴瘤.
- 为了研究双价OX40agonistaptamer (biROX40) 和CpG (收费类受体9刺激器) 的协同效应.
- 为了优化剂量,以获得最大的疗效和最小的副作用.
主要方法:
- 结合了biROX40,一种针对OX40受体的激动性吸收体,与免疫刺激剂CpG.
- 在动物模型中,为治疗淋巴瘤使用两种药物的减少,生物活性剂量.
- 评估免疫细胞增殖,细胞因子分泌和治疗地点和远部位的抗瘤疗效.
主要成果:
- 在极低剂量的biROX40 (0.32 mg/kg) 和CpG (1.39 mg/kg) 时观察到协同抗瘤疗效.
- 该组合促进了内CD8+T细胞增殖,抑制了调控性T细胞 (Treg) 增殖,并增强了记忆T细胞的产生.
- 显著的瘤回归发生在治疗和遥远的部位,表明强大的全身免疫反应和抑制复发.
结论:
- 使用biROX40和CpG的低剂量in situ组合疗法为增强癌症免疫治疗提供了一个有希望的策略.
- 这种方法克服了高剂量单剂疗法的局限性,例如免疫细胞耗尽.
- 这些发现支持这种组合疗法的潜力,以有效和更安全的癌症治疗.
相关概念视频
Tumor Immunotherapy
467
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
467
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Vaccines
332
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
332
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


